Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePancreatic safety in Japanese patients with type 2 diabetes treated with once weekly dulaglutide 0.75 mg up to 52 weeks in phase 3 clinical trials.AuthorsMasanori Emoto; Tomonori Oura; Akiko Matsui; Hirotaka Kazama; Noriyuki IwamotoPublicationEndocrine Journal, 2017, Vol 64, Issue 2, p191ISSN0918-8959Publication typeArticleDOI10.1507/endocrj.ej16-0365